Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:41 PM
Ignite Modification Date:
2025-12-25 @ 12:37 PM
NCT ID:
NCT04880395
Group ID:
EG001
Title:
Active Comparator : TDF/XTC Plus Dolutegravir (XTC Stands for Lamivudine OR Emtricitabine)
Description:
* TDF/FTC 300/200 mg, 1 coformulated tablet QD (FDC) plus Dolutegravir 50 mg, 1 tablet QD, OR
* TDF/3TC 300/300 mg, 1 coformulated tablet QD (FDC) plus Dolutegravir 50 mg, 1 tablet QD
Data related to the use of TDF/3TC or TDF/FTC was not discriminated. Both options used were considered as a single treatment arm: TDF/XTC plus dolutegravir.
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
9
Serious Number At Risk:
77
Other Number Affected:
21
Other Number At Risk:
77
Study:
NCT04880395
Results Section:
NCT04880395
Adverse Events Module:
NCT04880395